Skip to main content
. 2005 Jul;2(3):495–503. doi: 10.1602/neurorx.2.3.495

TABLE 3.

Behavioral Anomalies in Genetic Mouse Models of PD

Mouse Mutation Behavioral Impairments Effect of DA Agonists References
α-Synuclein overexpresor A53T + A30P: TH promoter Locomotor activity, righting on an inverted screen Reduced locomotor response to amphetamine and apomorphine 33,37
Human wild type: PDGFβ promoter Rotarod NA 35
Human wild type: Thy1 promoter Challenging beam, pole test, inverted grid, spontaneous activity, response to sensory stimuli, and fine motor skills (bin cotton use). Increased sensitivity to apomorphine, reduced response to amphetamine 39; Fleming, S. M., J. Salcedo, C. B. Hutson, E. Rockenstein, E. Masliah, M. S. Levine, and M.-F. Chesselet, submitted
Parkin knockout Exon 3 deletion Locomotor activity, alternation in T-maze Reduced response to amphetamine 51
Exon 3 deletion Challenging beam, response to sensory stimuli Decreased grooming response to intrastriatal DA 52; Fleming, S. M., N. T. Maidment, and M.-F. Chesselet, unpublished observations
Exon 7 deletion Startle response NA 53
Exon 2 deletion None detected in tests used No difference in locomotor activity after amphetamine 54
Spontaneous (Quaking mouse) Locomotor activity Enhanced response to SKF 38393, Reduced response to LY 171555 60
DJ-1 knockout Exon 2 Locomotor activity Reduced locomotor activity response to quinpirole 74
DJ-1 knockout Exon 1 stop codon None detected in tests used Reduced locomotor activity response to amphetamine 75
Nurr1 heterozygote Reduced Nurr1 Rotarod, locomotor activity Enhanced locomotor activity after methamphetamine 82
Pitx3-aphakia Loss of Pitx3 Challenging beam, pole test, and spontaneous activity Reversal with l-DOPA 61

NA = not assessed.